EMR vs XYL
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
EMR
XYL
Investment Advisor Scores
XYL
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EMR | XYL | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 21.4592 | 17.3913 | XYL |
| PEG Ratio | 1.7818 | 1.3219 | XYL |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.0% | 1.5% | EMR |
| Earnings Growth | 23.0% | 19.5% | EMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.1/100 | 52.4/100 | XYL |
| Profit Margin | 13.8% | 11.2% | EMR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | XYL |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EMR
MarkupPrice above SMA50, rising 50-day trend (3.6% over 20 days), RSI 63
XYL
MarkdownPrice below a falling SMA50 (slope -4.7%), weak momentum, RSI 33
Fundamentals Snapshot
| Metric | EMR | XYL |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 22.2 | 16.3 |
| Trailing P/E | 33.9 | 24.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | 0.3% | 0.2% |
| EPS | 4.68 | 4.20 |
| Dividend Yield | 0.01% | 0.02% |